Latest AI and machine learning research in oncology/hematology for healthcare professionals.
RNA therapeutics have progressed into a disruptive drug class quickly, replacing a variety of primary experimental agents which included vaccines, antisense oligonucleotides (ASOs), small interfering RNAs (siRNAs), aptamers and RNA editing systems. First-generation modalities, demonstrated by fomivirsen and pegaptanib were limited by vulnerability to nuclease attack, inefficient delivery and immun...
UNLABELLED: Anthracycline-induced cardiotoxicity remains a significant clinical challenge. We evaluated longitudinal electrocardiographic (ECG) repolarization changes in 36 lymphoma patients receiving doxorubicin-based chemotherapy and explored their association with subclinical cancer therapy-related cardiac dysfunction (CTRCD) using an exploratory machine learning-assisted approach. Standard 12‑...
BACKGROUND: Prostate cancer represents the second most common malignancy among men globally, necessitating accurate diagnostic methodologies for optim...
Neoadjuvant systemic therapy has emerged as a strategy to improve outcomes in high-risk localized genitourinary malignancies. In bladder cancer, neoad...
BACKGROUND AND OBJECTIVE: Gastric cancer is a heterogeneous and complicated epithelial cancers. Chronic H. pylori and EBV infection, as well as intest...
Colchicine, a well-known microtubule assembly inhibitor that binds to β-tubulin, has limited clinical utility due to high systemic toxicity. To enhanc...
Early detection of esophageal squamous cell carcinoma (ESCC) is critical for optimizing patient outcomes. Magnifying endoscopy and endoscopic ultrason...
BACKGROUND: Computed tomography (CT) is an essential diagnostic tool, but its associated radiation exposure raises significant concerns, especially fo...
To investigate the role of Benzo[a]pyrene (BaP) in driving the Correa cascade during gastric cancer development, we employed an integrated strategy co...
RATIONALE AND OBJECTIVES: To investigate the performance of deep learning image reconstruction (DLIR) at an ultra-low dose of approximately 4.5 mGy fo...
BACKGROUND: Artificial intelligence (AI)-based algorithms are being implemented in breast screening to detect breast cancers on mammographic images. W...
UNLABELLED: Timely diagnosis and intervention in colorectal cancer are critical to improving patient outcomes and limiting disease progression. Screen...
Imaging biomarkers have emerged as increasingly important endpoints in cancer clinical trials. Incorporating tumor metric reads as part of routine cli...
OBJECTIVES: To develop and validate machine learning (ML) models using clinical and contrast-enhanced CT (CECT) parameters to assess recurrence risk i...
OBJECTIVE: Radiologists often face challenges in differentiating benign from malignant sacral bone lesions due to their similar imaging characteristic...
Polysomnography (PSG)-based accurate sleep staging is essential to monitor sleep quality and sleep-related disorders. Despite previous attempts for im...
Quantitative remote wound monitoring has the potential to shorten patient recovery time and alleviate the workload of healthcare professionals. In thi...
This work addresses the challenge of accurately identifying living circulating tumor cell (CTC) from contaminating leukocytes by developing a novel, f...
BACKGROUND: Immune checkpoint inhibitor therapy (ICI) with nivolumab+ipilimumab is a first-line (1L) standard for metastatic clear cell renal cell car...